FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080692225> ?p ?o ?g. }

• W2080692225 endingPage "2048" @default.
• W2080692225 startingPage "2040" @default.
• W2080692225 abstract "Nitric oxide is a radical with vasodilating properties that protects tissues from neutrophil-mediated ischemia-reperfusion injury in the heart and intestine. Previous studies in our laboratory suggested that L-arginine, a nitric oxide precursor, can protect skin flaps from ischemia-reperfusion injury. In this study, we examined the effects of L-arginine on the survival of myocutaneous flaps in a large animal model and established whether this effect was mediated by nitric oxide and neutrophils. Two superiorly based 15 x 7.5 cm epigastric myocutaneous island flaps were dissected in 15 Yorkshire pigs weighing 45 to 50 kg. One of the flaps was subjected to 6 hours of arterial ischemia and then reperfused for 4 hours (ischemia-reperfusion flaps), whereas the other flap was used as a non-ischemic control (non-ischemia-reperfusion flaps). The flaps were divided into four groups: control non-ischemia-reperfusion flaps that received only saline (group I); ischemia-reperfusion flaps that were treated with saline (group II); and flaps treated with either L-arginine (group III) or Nomega-nitro-L-arginine methylester (L-NAME), a nitric oxide synthase competitive inhibitor, plus L-arginine in equimolar amounts (group IV). These drugs were administered as an intravenous bolus 10 minutes before the onset of reperfusion, followed by a 1-hour continuous intravenous infusion. Full-thickness muscle biopsies were taken at baseline, 3 and 6 hours of ischemia, and 1 and 4 hours of reperfusion. The biopsies were evaluated by counting neutrophils and measuring myelo-peroxidase activity. At the end of the experiment, skeletal muscle necrosis was quantified using the nitroblue tetrazolium staining technique, and a full-thickness biopsy of each flap was used for determination of water content. Statistical analysis was performed using analysis of variance and the Newman-Keuls test. Non-ischemia-reperfusion flaps showed no muscle necrosis. Ischemia-reperfusion flaps treated with saline had 68.7 +/- 9.1 percent necrosis, which was reduced to 21.9 +/- 13.6 percent with L-arginine (p < 0.05). L-NAME administered concomitantly with L-arginine demonstrated a necrosis rate similar to that of saline-treated ischemia-reperfusion flaps (61.0 +/- 17.6 percent). Neutrophil counts and myeloperoxidase activity after 4 hours of reperfusion were significantly higher in ischemia-reperfusion flaps treated with L-NAME and L-arginine as compared with the other three groups (p < 0.05). Flap water content increased significantly in ischemia-reperfusion flaps treated with saline and L-NAME plus L-arginine versus non-ischemia-reperfusion flaps (p < 0.02) and L-arginine-treated ischemia-reperfusion flaps (p < 0.05). There was no difference in flap water content between ischemia-reperfusion flaps treated with L-arginine and non-ischemia-reperfusion flaps. Administration of L-arginine before and during the initial hour of reperfusion significantly reduced the extent of flap necrosis, neutrophil accumulation, and edema due to ischemia-reperfusion injury in a large animal model. This protective effect is completely negated by the use of the nitric oxide synthase blocker L-NAME. The mechanism of action seems to be related to nitric oxide-mediated suppression of ischemia-reperfusion injury through neutrophil activity inhibition." @default.
• W2080692225 created "2016-06-24" @default.
• W2080692225 creator A5002850823 @default.
• W2080692225 creator A5004612477 @default.
• W2080692225 creator A5044228643 @default.
• W2080692225 date "1998-11-01" @default.
• W2080692225 modified "2023-09-27" @default.
• W2080692225 title "Use of a Nitric Oxide Precursor to Protect Pig Myocutaneous Flaps from Ischemia-Reperfusion Injury" @default.
• W2080692225 cites W1967848145 @default.
• W2080692225 cites W1968332152 @default.
• W2080692225 cites W1977101995 @default.
• W2080692225 cites W1998332441 @default.
• W2080692225 cites W2029491963 @default.
• W2080692225 cites W2048014052 @default.
• W2080692225 cites W2048635427 @default.
• W2080692225 cites W2057461947 @default.
• W2080692225 cites W2061408585 @default.
• W2080692225 cites W2061897451 @default.
• W2080692225 cites W2064131872 @default.
• W2080692225 cites W2088134400 @default.
• W2080692225 cites W2088858758 @default.
• W2080692225 cites W2090522535 @default.
• W2080692225 cites W2093518775 @default.
• W2080692225 cites W2097321718 @default.
• W2080692225 cites W2125076307 @default.
• W2080692225 cites W2134363454 @default.
• W2080692225 cites W2142313665 @default.
• W2080692225 cites W2344300526 @default.
• W2080692225 cites W2396318432 @default.
• W2080692225 doi "https://doi.org/10.1097/00006534-199811000-00035" @default.
• W2080692225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9811002" @default.
• W2080692225 hasPublicationYear "1998" @default.
• W2080692225 type Work @default.
• W2080692225 sameAs 2080692225 @default.
• W2080692225 citedByCount "46" @default.
• W2080692225 countsByYear W20806922252012 @default.
• W2080692225 countsByYear W20806922252015 @default.
• W2080692225 countsByYear W20806922252019 @default.
• W2080692225 countsByYear W20806922252020 @default.
• W2080692225 countsByYear W20806922252021 @default.
• W2080692225 crossrefType "journal-article" @default.
• W2080692225 hasAuthorship W2080692225A5002850823 @default.
• W2080692225 hasAuthorship W2080692225A5004612477 @default.
• W2080692225 hasAuthorship W2080692225A5044228643 @default.
• W2080692225 hasConcept C126322002 @default.
• W2080692225 hasConcept C141071460 @default.
• W2080692225 hasConcept C2777397205 @default.
• W2080692225 hasConcept C2777622882 @default.
• W2080692225 hasConcept C2780114680 @default.
• W2080692225 hasConcept C42219234 @default.
• W2080692225 hasConcept C43376680 @default.
• W2080692225 hasConcept C519581460 @default.
• W2080692225 hasConcept C541997718 @default.
• W2080692225 hasConcept C71924100 @default.
• W2080692225 hasConceptScore W2080692225C126322002 @default.
• W2080692225 hasConceptScore W2080692225C141071460 @default.
• W2080692225 hasConceptScore W2080692225C2777397205 @default.
• W2080692225 hasConceptScore W2080692225C2777622882 @default.
• W2080692225 hasConceptScore W2080692225C2780114680 @default.
• W2080692225 hasConceptScore W2080692225C42219234 @default.
• W2080692225 hasConceptScore W2080692225C43376680 @default.
• W2080692225 hasConceptScore W2080692225C519581460 @default.
• W2080692225 hasConceptScore W2080692225C541997718 @default.
• W2080692225 hasConceptScore W2080692225C71924100 @default.
• W2080692225 hasIssue "6" @default.
• W2080692225 hasLocation W20806922251 @default.
• W2080692225 hasLocation W20806922252 @default.
• W2080692225 hasOpenAccess W2080692225 @default.
• W2080692225 hasPrimaryLocation W20806922251 @default.
• W2080692225 hasRelatedWork W2009398655 @default.
• W2080692225 hasRelatedWork W2062533504 @default.
• W2080692225 hasRelatedWork W2069536567 @default.
• W2080692225 hasRelatedWork W2079776789 @default.
• W2080692225 hasRelatedWork W2090126574 @default.
• W2080692225 hasRelatedWork W2319824260 @default.
• W2080692225 hasRelatedWork W2353715290 @default.
• W2080692225 hasRelatedWork W2365533218 @default.
• W2080692225 hasRelatedWork W2389773480 @default.
• W2080692225 hasRelatedWork W2415978481 @default.
• W2080692225 hasVolume "102" @default.
• W2080692225 isParatext "false" @default.
• W2080692225 isRetracted "false" @default.
• W2080692225 magId "2080692225" @default.
• W2080692225 workType "article" @default.